In part four of Pharmaceutical Executive’s conversation with Susan Thomas, LucyRx’s chief commercial officer, Thomas delves into why GLP-1 coverage requires a more targeted approach than a simple yes or no decision. The interview explores how plan sponsors can better understand their member population and identify where coverage can have the greatest impact.
The coverage also highlights the challenge employers face in balancing access and affordability. The conversation with Thomas points to a more thoughtful approach to coverage, one that helps employers support the members who need it most while making spending decisions with greater confidence
Share